Neurocrine Biosciences (NBIX) Short-term Investments (2009 - 2026)
Neurocrine Biosciences (NBIX) reported Short-term Investments of $96.4 million for Q3 2026, down 87.6% from $774.6 million a year earlier but up 67.9% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Short-term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Neurocrine Biosciences posted Short-term Investments of $767.4 million, down 9.0% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 4.6% (FY2020 to FY2025).
- By year, Short-term Investments came in at $843.1 million in FY2024 (+8.0%), $780.5 million in FY2023 (+7.4%), $726.4 million in FY2022 (+96.1%) and $370.5 million in FY2021 (-39.6%).
- Five-year quarterly Short-term Investments spans a low of $57.4 million in Q2 2026 and a high of $1.05 billion in Q1 2026.
- Year over year, Short-term Investments gained in two of the last eight quarters, with an average decline of 22.6%.
- The high point for year-over-year Short-term Investments in five years was Q1 2023 (growth of 100.4%); the low point was Q2 2026 (a decline of 91.9%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $57.4 million (Q2 2026), $1.05 billion (Q1 2026) and $767.4 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 96.40 Mn |
| Jun 30, 2026 | 57.40 Mn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 767.40 Mn |
| Sep 30, 2025 | 774.60 Mn |
| Jun 30, 2025 | 711.60 Mn |
| Mar 31, 2025 | 749.40 Mn |
| Dec 31, 2024 | 843.10 Mn |
| Sep 30, 2024 | 878.90 Mn |
| Jun 30, 2024 | 899.20 Mn |
| Mar 31, 2024 | 814.30 Mn |
| Dec 31, 2023 | 780.50 Mn |
| Sep 30, 2023 | 801.40 Mn |
| Jun 30, 2023 | 816.50 Mn |
| Mar 31, 2023 | 790.80 Mn |
| Dec 31, 2022 | 726.40 Mn |
| Sep 30, 2022 | 587.20 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 394.70 Mn |
| Dec 31, 2021 | 370.50 Mn |
API Access
Neurocrine Biosciences Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();